Multilocus sequence typing of 169 non-O157 enterohemorrhagic Escherichia coli (EHEC) isolated from patients with hemolytic uremic syndrome (HUS) demonstrated 29 different sequence types (STs); 78.1% of these strains clustered in 5 STs. From all STs and serotypes identifi ed, we established a reference panel of EHEC associated with HUS (HUSEC collection).
E
nterohemorrhagic Escherichia coli (EHEC) strains are a highly pathogenic subgroup of Shiga toxin-producing E. coli (STEC) that cause severe human diseases, including bloody diarrhea and hemolytic uremic syndrome (HUS) (1) . The ability to cause severe human disease differentiates EHEC from other STEC found in the environment that are less pathogenic or nonpathogenic. E. coli O157:H7 is the most frequent EHEC implicated as a cause of HUS (2) , but non-O157:H7 EHEC are variably present as the only pathogens in stools from HUS patients (1, 3, 4) .
A recent phylogenetic analysis of E. coli isolated from humans and animals in different geographic areas by multilocus sequence typing (MLST), the current standard for phylogenetic analyses of bacteria, indicated extensive allelic variations and homolog recombinations in pathogenic lineages and demonstrated repeated and independent evolution of pathogenic strains (5, 6) . However, only a limited number of EHEC associated with HUS have been so investigated. Therefore, we performed a comprehensive MLSTbased examination of the molecular phylogeny of EHEC isolated from HUS patients and established a collection of representative HUS-associated enterohemorrhagic E. coli (HUSEC) (www.ehec.org).
The Study
From 1996 through 2006, 524 EHEC were isolated as the only pathogens from fecal samples of epidemiologically unrelated patients with HUS (1 strain per patient). The isolation was achieved by using previously described procedures (7) . The isolates were confi rmed as E. coli by API 20 E (bioMérieux, Marcy l'Etoile, France) and serotyped (8) by using antisera against E. coli O antigens 1-181 and H antigens 1-56. In all nonmotile isolates from serogroups O26, O103, O111, O145, and O157, fl iC genes were genotyped (9, 10) . MLST was performed as described previously (6) with small modifi cations (11) . Phylogenetic analyses were based on allelic data that used the BURST algorithm (12) to achieve a more robust interpretation of the clustering and to reduce the infl uences by the effects of the recombination, which are widespread in E. coli (6) . In addition, the stringent defi nition of clonal complexes (CCs), with which strains sharing at least 6 identical alleles are grouped into the same CC, was applied. The minimum spanning tree was generated from the allelic profi les by using Shigella dysenteriae strain M1354 (ST243, by using data from http://web.mpiib-berlin.mpg.de/mlst/dbs/Ecoli) as outgroup (online Appendix Figure, available from www. cdc.gov/EID/content/14/8/1287-appG.htm).
Among 524 EHEC isolated from HUS patients, 355 (67.7%) belonged to serotypes O157:H7/H -(249 were non-sorbitol-fermenting EHEC O157:H7/H -and 106 were sorbitol-fermenting EHEC O157:H -), and 169 (32.3%) belonged to 34 non-O157 serotypes. Because the phylogeny of E. coli O157:H7/ H -has been extensively studied and is well established (5,13), we focused on MLST analysis of the 169 non-O157 strains, which represent all non-O157 EHEC serotypes from German HUS patients during the study period. We performed MLST analysis of only a subset of 10 O157 strains as controls.
MLST analysis of 169 non-O157 EHEC isolates distinguished 29 different sequence types (STs), which clustered into 10 CCs and 12 singletons ( Table 1 ). The predominant ST was ST21, which consisted of 43 isolates (25.4% of non-O157 EHEC), followed by ST29 (30 isolates, 17.8%), ST32 (30 isolates, 17.8%), ST17 (15 isolates, 8.9%), and ST16 (14 isolates, 8.3%) ( Table 1) . These 5 STs included 78.1% of all HUS-associated non-O157 EHEC. The remaining 21.9% (n = 37) of the non-O157 EHEC strains belonged to 24 other STs that comprised only 1-3 strains; 14 of these STs were found only once (Table 1) . Among the 10 CCs identifi ed, CC29 was the most frequent. It comprised 89 strains of 5 STs, corresponding to 60.1% of 148 strains that could be assigned to a CC and to 52.7% of all non-O157 EHEC (Table 1 ). After CC29, CC32 and CC20 were the most frequently identifi ed CCs (Table 1) .
The predominant serotypes identifi ed among the 169 non-O157 HUS-associated EHEC were O26:H11/H-(n = 72; 42.6%), O145:H28/H-(n = 32; 18.9%), O111:H8/H-(n = 14; 8.3%), and O103:H2/H -(n = 14; 8.3%). The nonmotile strains within these serogroups shared the H antigenencoding fl iC gene with the motile strains that expressed the respective H antigen (Table 1) . These 8 serotypes together constituted 132 (78.1%) of the non-O157 EHEC associated with HUS, whereas the other 37 strains (21.9%) belonged to 26 different serotypes, 17 of which contained only a single isolate ( Table 1) .
The most frequent serotypes including O26:H11/H-, O103:H2/H-, O111:H8/H-, and O145:H28/H-clustered into the 5 most prevalent STs (Table 1) . However, not all isolates of the same serotype always belonged to the same ST ( within these serotypes ( Table 2 ). The strains included in this HUSEC collection were reserotyped and characterized for their stx genotypes and the presence of the eae gene (Table 2) . Phenotypic characteristics and additional properties such as putative virulence determinants are available at www.EHEC.org.
Conclusions
Most (81.1%) of the non-O157 EHEC clustered into 3 CCs and belonged to a limited number of serotypes. These strains were recovered independently from different regions in Germany over an 11-year period. For the remaining strains, epidemiologic support is not as strong, and the clonal analysis demonstrated that their chromosomal backgrounds are highly divergent from those of CC29, CC32, and CC20. In 14 STs, we have only 1 isolate. In these cases, excluding concurrent or recent infection by E. coli O157 serologically is even more important. This exclusion was not always possible because patients' serum for the investigation of immunoglobulin M anti-O157 lipopolysaccharide antibodies is frequently not available. However, at least some of these strains might represent emerging clones in the human population, such as O111:H10 (10), O113:H21 (14) , and O121:H19 (15) . Thus, strains of these serotypes included in our HUSEC collection can be used in future studies as a reference to compare EHEC isolated in other countries from HUS patients. This would allow timely discovery of the emergence of new non-O157 clones associated with HUS and the virulence traits that they contain (www.ehec.org).
